<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo>, including <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anticardiolipin antibodies, are increasingly recognized as a cause of <z:e sem="disease" ids="C1301721" disease_type="Disease or Syndrome" abbrv="">neurological morbidity</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>They may occur with or without evidence of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and have been associated with <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0002076'>migraine</z:hpo>, and <z:e sem="disease" ids="C0009676" disease_type="Mental or Behavioral Dysfunction" abbrv="">confusional states</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Their role as etiologic or contributing factors in neurobehavioral and neuropsychiatric syndromes of obscure etiology has not been emphasized </plain></SENT>
<SENT sid="3" pm="."><plain>The cases of 7 patients who were referred for evaluation of behavior abnormalities and had <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> are presented, and the potential relationships of the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome to behavioral alterations are discussed </plain></SENT>
</text></document>